How to bolster the antifungal pipeline

被引：388

作者：

Denning, David W. ^{[1
,2
]}

Bromley, Michael J. ^{[1
,3
]}

机构：

[1] Univ Manchester, Manchester Acad Hlth Sci Ctr, Manchester, Lancs, England

[2] Univ S Manchester Hosp, Natl Aspergillosis Ctr, Manchester M20 8LR, Lancs, England

[3] Univ Manchester, Manchester Fungal Infect Grp, Manchester, Lancs, England

来源：

SCIENCE | 2015年 / 347卷 / 6229期

关键词：

VORICONAZOLE; THERAPY; DRUG;

D O I：

10.1126/science.aaa6097

中图分类号：

O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];

学科分类号：

07 ; 0710 ; 09 ;

摘要：

引用

页码：1414 / 1416

页数：3

共 14 条

[1] Therapeutic drug monitoring (TDM) of antifungal agents: guidelines from the British Society for Medical Mycology [J].

Ashbee, H. Ruth ;

Barnes, Rosemary A. ;

Johnson, Elizabeth M. ;

Richardson, Malcolm D. ;

Gorton, Rebecca ;

Hope, William W. .

JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2014, 69 (05) :1162-1176

[2] Hidden Killers: Human Fungal Infections [J].

Brown, Gordon D. ;

Denning, David W. ;

Gow, Neil A. R. ;

Levitz, Stuart M. ;

Netea, Mihai G. ;

White, Theodore C. .

SCIENCE TRANSLATIONAL MEDICINE, 2012, 4 (165)

[3] Voriconazole for chronic pulmonary aspergillosis: a prospective multicenter trial [J].

Cadranel, J. ;

Philippe, B. ;

Hennequin, C. ;

Bergeron, A. ;

Bergot, E. ;

Bourdin, A. ;

Cottin, V. ;

Jeanfaivre, T. ;

Godet, C. ;

Pineau, M. ;

Germaud, P. .

EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES, 2012, 31 (11) :3231-3239

[4] Fungal allergy in asthma-state of the art and research needs [J].

Denning, David W. ;

Pashley, Catherine ;

Hartl, Domink ;

Wardlaw, Andrew ;

Godet, Cendrine ;

Del Giacco, Stefano ;

Delhaes, Laurence ;

Sergejeva, Svetlana .

CLINICAL AND TRANSLATIONAL ALLERGY, 2014, 4

[5] Efficacy and safety of voriconazole in the treatment of acute invasive aspergillosis [J].

Denning, DW ;

Ribaud, P ;

Milpied, N ;

Caillot, D ;

Herbrecht, R ;

Thiel, E ;

Haas, A ;

Ruhnke, M ;

Lode, H .

CLINICAL INFECTIOUS DISEASES, 2002, 34 (05) :563-571

[6]

European Crop Protection Association, ASS EC IMP AZ EUR AG

[7] Voriconazole versus amphotericin B for primary therapy of invasive aspergillosis [J].

Herbrecht, R ;

Denning, DW ;

Patterson, TF ;

Bennett, JE ;

Greene, RE ;

Oestmann, JW ;

Kern, WV ;

Marr, KA ;

Ribaud, P ;

Lortholary, O ;

Sylvester, R ;

Rubin, RH ;

Wingard, JR ;

Stark, P ;

Durand, C ;

Caillot, D ;

Thiel, E ;

Chandrasekar, PH ;

Hodges, MR ;

Schlamm, HT ;

Troke, PF ;

de Pauw, B .

NEW ENGLAND JOURNAL OF MEDICINE, 2002, 347 (06) :408-415

[8] The Nationwide Austrian Aspergillus Registry: a prospective data collection on epidemiology, therapy and outcome of invasive mould infections in immunocompromised and/or immunosuppressed patients [J].

Perkhofer, S. ;

Lass-Floerl, C. ;

Hell, M. ;

Russ, G. ;

Krause, R. ;

Hoenigl, M. ;

Geltner, C. ;

Auberger, J. ;

Gastl, G. ;

Mitterbauer, M. ;

Willinger, B. ;

Knoebl, P. ;

Resch, G. ;

Waldner, R. ;

Makrai, A. ;

Hartmann, G. ;

Girschikofsky, M. ;

Greil, R. .

INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS, 2010, 36 (06) :531-536

[9] A comprehensive regulatory framework to address the unmet need for new antibacterial treatments [J].

Rex, John H. ;

Eisenstein, Barry I. ;

Alder, Jeff ;

Goldberger, Mark ;

Meyer, Robert ;

Dane, Aaron ;

Friedland, Ian ;

Knirsch, Charles ;

Sanhai, Wendy R. ;

Tomayko, John ;

Lancaster, Cindy ;

Jackson, Jennifer .

LANCET INFECTIOUS DISEASES, 2013, 13 (03) :269-275

[10]

Roemer T, 2013, NAT CHEM BIOL, V9, P222, DOI [10.1038/NCHEMBIO.1205, 10.1038/nchembio.1205]

← 1 2 →